Does Ozempic lower blood pressure and raise heart rate?

Two things happen to your circulation on a GLP-1 drug, and they pull in opposite directions. Your blood pressure usually drifts down a little. Your resting pulse usually drifts up a little. Both changes are real, both are small, and neither is a reason to panic.

That two-way effect confuses people. One person sees a lower blood-pressure reading and wonders whether they can drop a pill. Another feels a faster heartbeat and worries the drug is straining the heart. This article gives the actual numbers for both, drawn from a 2026 evidence review and the four US drug labels.

Does Ozempic lower blood pressure?

Yes, by a modest amount. A 2026 state-of-the-art review in the American Journal of Hypertension pooled the trial evidence and found that GLP-1 receptor agonists lower systolic blood pressure by about 2 to 5 mm Hg.1

That reduction held across different groups: people with type 2 diabetes, people with obesity, and people at high cardiovascular risk.1 It is smaller than the drop a dedicated blood-pressure medicine produces, but the review notes it adds useful benefit on top of standard treatment and, at a population level, can translate into lower cardiovascular risk.1

Why does the pressure drop?

Most of the fall comes from weight loss. As body weight comes down, the heart and blood vessels work under less strain, and blood pressure eases.1

The review describes smaller, weight-independent effects as well. GLP-1 drugs appear to promote mild salt and water excretion (natriuresis), improve the function of the blood-vessel lining, and reduce inflammation in the vessel wall.1 These effects add to the weight-loss benefit rather than replacing it.

Does Ozempic raise your heart rate?

Yes, and this is one of the most consistent effects of the whole drug class. The same 2026 review describes a modest, dose-dependent rise in resting heart rate of about 2 to 5 beats per minute, seen most clearly with the long-acting agents.1

This is not only a research finding. All four US labels report the same rise from their own trials: Ozempic lists a mean increase of 2 to 3 beats per minute, Wegovy 1 to 4, Mounjaro 2 to 4, and Zepbound 1 to 3.3456

Mean resting heart-rate increase versus placebo, taken from each drug's current US prescribing information. The populations differ (diabetes trials for Ozempic and Mounjaro, weight-management trials for Wegovy and Zepbound), so these figures are not a head-to-head comparison.3456

Should a faster pulse worry you?

For most people, no. Large cardiovascular outcome trials have not found that this small heart-rate rise leads to more heart attacks or strokes.1

The labels treat the rise as worth watching rather than alarming. The Wegovy label carries a specific instruction to monitor heart rate at regular intervals and to stop the drug if a patient has a sustained increase in resting heart rate.3 The Mounjaro label states plainly that the clinical relevance of the heart-rate increase is uncertain.5

The rise matters more in some people than others. The review flags a theoretical concern for people with ischemic heart disease or an arrhythmia, where a higher resting pulse is less welcome.1 In one small heart-failure trial (LIVE), liraglutide raised heart rate by about 7 beats per minute, more than the class average, which is why people with heart failure need individual medical advice.1

Blood pressure usually drifts down a little. Resting pulse usually drifts up a little. Both effects are small, and neither is a reason to change a prescription on your own. Summarising the 2026 American Journal of Hypertension review

Can you cut your blood pressure pills?

This is the question with a real safety risk attached, so the answer is firm: do not adjust a prescribed blood-pressure medicine on your own.1

A GLP-1 drug can lower blood pressure enough that an existing antihypertensive or diuretic becomes too strong for you. The review specifically warns about interactions with volume-regulating medicines and about low blood pressure on standing (orthostatic hypotension), especially in older or frail adults and in people taking diuretics or an SGLT2 inhibitor.1 The Zepbound label lists decreased blood pressure and orthostatic hypotension among its reported reactions.6

The practical point is simple. A lower reading is good news, but it is a reason to see your doctor, who can measure your blood pressure over time and decide whether any medicine should change. Cutting or halving a pill yourself can send your pressure the wrong way.

What does real-world use show?

Trial averages describe the typical person, but routine care is messier. A 2026 real-world study from a hospital in the United Arab Emirates followed 143 adults on GLP-1-based therapy for about seven months and measured their blood pressure.2

On average, systolic blood pressure fell by 3.59 mm Hg, landing squarely inside the review's 2 to 5 mm Hg range.2 But the responses varied widely: about half of patients showed little change, roughly a third improved, and a smaller group actually went up.2 That spread is the honest picture. The average is a small drop, but your own number can move either way.

In one sentence: GLP-1 drugs like Ozempic usually lower systolic blood pressure by about 2 to 5 mm Hg and raise resting heart rate by about 2 to 5 beats per minute, both effects are small and generally well tolerated, the heart-rate rise deserves attention if you have heart disease or an arrhythmia, and you should never change a blood-pressure medicine without your doctor.